A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults

NCT03208101 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Tetanus
Pertussis
Poliomyelitis
Hepatitis B
Haemophilus Influenzae Type b Infection

Interventions

BIOLOGICAL: DTP-HepB-IPV-Hib vaccine
BIOLOGICAL: DTP-HepB-Hib vaccine & IPV

Sponsor

LG Chem